Jul 2026· International Journal of Molecular Sciences· Vol 27· 0 citations· 54 references
Medicine
TL;DR
Two biologically distinct PD subtypes are identified with divergent molecular architecture and systemic neurodegeneration beyond conventional motor phenotyping beyond conventional motor phenotyping.
Abstract
Parkinson’s disease (PD) is the second most common age-related neurodegenerative disorder, yet it remains unclear whether cortical architecture can reveal biologically distinct subtypes with distinct molecular and serum biomarker signatures. Two hundred PD patients and 121 healthy controls underwent structural MRI. Subject-specific cortical similarity networks were constructed using Morphometric INverse Divergence (MIND), and subtypes were identified with HYDRA. Spatial patterns were linked to regional gene expression from the Allen Human Brain Atlas through partial least squares regression, followed by functional and cell-type enrichment analyses. Serum neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) were quantified using single-molecule array assays. No significant MIND differences emerged when PD patients were analysed as a single group. HYDRA identified two subtypes (ARI = 0.85) with divergent cortical organization that only partially overlapped with conventional motor phenotypes. Cluster 1 exhibited temporo-parietal MIND increases associated with synaptic and oligodendroglial signatures, without serum biomarker associations. Cluster 2 showed widespread fronto-cingulate MIND reductions enriched for mitochondrial, lysosomal, and proteostatic pathways, including the KEGG Parkinson’s disease pathway, and these reductions correlated with higher serum NfL and GFAP. These findings reveal two biologically distinct PD subtypes with divergent molecular architecture and systemic neurodegeneration beyond conventional motor phenotyping.
Type 2 diabetes (T2D) is characterized by substantial clinical heterogeneity, yet its neurobiological substrates remain unclear. Here, we leverage normative modelling of cortical morphometric networks to quantify individual-level brain deviations using structural MRI data from 3,723 participants (1,941 T2D patients and...
Xiaoyue Wang, Zhizhong Sun, Jian-Cheng Cao et al.· bioRxiv· 0 citations
It is shown that TLE patients have structural changes in two brain regions, the posterior cingulate cortex and dorsolateral prefrontal cortex, linked to slower processing speed and poorer working memory, which helps explain how microscopic gene patterns may contribute to large‐scale brain changes and cognitive difficul...
Yaping Dong, Shuai Wang, Jingjie Luo et al.· Epilepsia Open· 0 citations
A conserved transcriptional architecture underlying AD progression is revealed, organized around coordinated immune activation, synaptic loss, and myelin remodeling, with the cerebellum following a distinct trajectory.
F. Ecca, S. Song, M. Naymik et al.· bioRxiv· 0 citations
A single cell atlas of middle temporal gyrus revealed a unique cellular-level view of sex-specific transcriptional changes in AD, illuminating GWAS identification of sex-specific AD genes.
Le Zhang, Tian-Yu Liu, Chuan He et al.· Journal of Alzheimer's Disea...· 1 citation
It is suggested that integrating disease-state transcriptomics with genetic prioritization can refine PD risk-gene nomination and uncover regulatory programs that may be missed by GWAS alone.
Isabel Alfradique-Dunham, Jessie Sanford, Meng-Han Liu et al.· bioRxiv· 0 citations
It is demonstrated that peripheral blood transcriptomic signatures capture aspects of PD pathophysiology that are not fully explained by nigrostriatal dopaminergic degeneration alone, serving as potential prognostic biomarkers for cognitive impairment and FOG.